Zacks Investment Research on MSN

NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases

Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
News-Medical.Net

Genomic sequencing may expand newborn screening beyond biochemical tests

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
Labroots

Accelerating Control of Drug-resistant Tuberculosis with Targeted Next-generation Sequencing: Country Success Stories from the Front Lines

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people ...

FamilyTreeDNA Advances Genetic Genealogy with Precision Genomics Partnership

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
dvm360

Precision diagnostics: A Q&A on next-generation sequencing with Janina Krumbeck, PhD

Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this ...
PharmiWeb

Next Generation Sequencing (NGS) Market Trends: In-Depth Analysis of Market Growth & Forecast Up To 2030

Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, ...
Healio

Most patients with advanced cancer do not undergo next-generation sequencing testing

Please provide your email address to receive an email when new articles are posted on . Real-world data show that only about 30% to 40% of patients with the most common cancers receive NGS testing.
Kaleido Scope

NEXT GEN SEQUENCING AND DELETION/DUPLICATION ANALYSIS OF NF1 and SPRED1 ONLY (NFSP-NG)

Patients with multiple CALMs w/wo skinfold freckling and no other typical NF1 associated features (Lisch nodules, bone abnormalities, neurofibromas, optic pathway gliomas). The DNA-based ...